Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18434611rdf:typepubmed:Citationlld:pubmed
pubmed-article:18434611lifeskim:mentionsumls-concept:C0939930lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C1122976lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C0023434lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C0876956lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C1539721lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C1539386lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C0683598lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C1880177lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:18434611lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:18434611pubmed:issue2lld:pubmed
pubmed-article:18434611pubmed:dateCreated2008-7-8lld:pubmed
pubmed-article:18434611pubmed:abstractTextTo identify novel genes involved in the molecular pathogenesis of chronic lymphocytic leukemia (CLL) we performed a serial analysis of gene expression (SAGE) in CLL cells, and compared this with healthy B cells (nCD19(+)). We found a high level of similarity among CLL subtypes, but a comparison of CLL versus nCD19(+) libraries revealed 55 genes that were over-represented and 49 genes that were down-regulated in CLL. A gene ontology analysis revealed that TOSO, which plays a functional role upstream of Fas extrinsic apoptosis pathway, was over-expressed in CLL cells. This finding was confirmed by real-time reverse transcription-polymerase chain reaction in 78 CLL and 12 nCD19(+) cases (P < .001). We validated expression using flow cytometry and tissue microarray and demonstrated a 5.6-fold increase of TOSO protein in circulating CLL cells (P = .013) and lymph nodes (P = .006). Our SAGE results have demonstrated that TOSO is a novel over-expressed antiapoptotic gene in CLL.lld:pubmed
pubmed-article:18434611pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:languageenglld:pubmed
pubmed-article:18434611pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:citationSubsetAIMlld:pubmed
pubmed-article:18434611pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18434611pubmed:statusMEDLINElld:pubmed
pubmed-article:18434611pubmed:monthJullld:pubmed
pubmed-article:18434611pubmed:issn1528-0020lld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:MorrisKellyKlld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:GribbenJohn...lld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:OwenCarolynClld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:ZagoMarco AMAlld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:SilvaWilson...lld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:FalcãoRoberto...lld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:RizzattiEdgar...lld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:Proto-Siqueir...lld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:PanepucciRodr...lld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:LeeAbigailAlld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:CaretaFrancis...lld:pubmed
pubmed-article:18434611pubmed:authorpubmed-author:ClearAndrewAlld:pubmed
pubmed-article:18434611pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18434611pubmed:day15lld:pubmed
pubmed-article:18434611pubmed:volume112lld:pubmed
pubmed-article:18434611pubmed:ownerNLMlld:pubmed
pubmed-article:18434611pubmed:authorsCompleteYlld:pubmed
pubmed-article:18434611pubmed:pagination394-7lld:pubmed
pubmed-article:18434611pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:18434611pubmed:meshHeadingpubmed-meshheading:18434611...lld:pubmed
pubmed-article:18434611pubmed:meshHeadingpubmed-meshheading:18434611...lld:pubmed
pubmed-article:18434611pubmed:meshHeadingpubmed-meshheading:18434611...lld:pubmed
pubmed-article:18434611pubmed:meshHeadingpubmed-meshheading:18434611...lld:pubmed
pubmed-article:18434611pubmed:meshHeadingpubmed-meshheading:18434611...lld:pubmed
pubmed-article:18434611pubmed:meshHeadingpubmed-meshheading:18434611...lld:pubmed
pubmed-article:18434611pubmed:meshHeadingpubmed-meshheading:18434611...lld:pubmed
pubmed-article:18434611pubmed:year2008lld:pubmed
pubmed-article:18434611pubmed:articleTitleSAGE analysis demonstrates increased expression of TOSO contributing to Fas-mediated resistance in CLL.lld:pubmed
pubmed-article:18434611pubmed:affiliationHematology Division and Center for Cell-Based Therapy, Faculty of Medicine of Ribeirão Preto, University of São Paulo, São Paulo, Brazil.lld:pubmed
pubmed-article:18434611pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18434611pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:18434611pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
entrez-gene:9214entrezgene:pubmedpubmed-article:18434611lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18434611lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18434611lld:pubmed